Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Duke ScientificCorporation

We are pleased to announce that on Oct. 3, Fisher Scientific International Inc. completed it's acquisition of Duke Scientific Corporation. This change means that Duke Scientific Corporation joins a publicly held company with a proven track record of providing high quality products and services to the scientific community for more than 100 years. Duke Scientific Corporation will be part of the Fisher Immunodiagnostics unit of Fisher Scientific International Inc. and our business will remain in California.Duke Scientific Corporation will continue to operate as before, providing the same high quality products and technical services. The Duke brand will also remain intact and be fully supported. I encourage you to continue to interact with Duke Scientific Corporation just as you normally would. We anticipate no substantive changes in our workforce, and therefore the transition to our new ownership should be transparent. We are very excited about this great opportunity to become part of Fisher Scientific International Inc. and to expand our capability to produce world-class products and the highest quality technical support. Your past and ongoing relationship with Duke Scientific Corporation is greatly valued and appreciated. If you have further questions please feel free to contact us.


Contact Details:
46360 Fremont Boutevard
Fremont
California
94538
United States of America
Tel:1-510-979-5000
Fax:1-510-979-5002
Email:dukeinfo@microgenics.com
WWW:

www.dukesci.com/




Loading...

BioNews Results for Duke ScientificCorporation:

American Heart Association Late-Breaking Clinical Trial Report: New Reversible Antiplatelet Drug no More Effec
TickerTech.com:  Nov 16 2009 2:02AM Matching: duke scientific
American Heart Association Late-Breaking Clinical Trial Report: New Reversible Antiplatelet Drug no More Effec
KOTA Territory News:  Nov 16 2009 12:35AM Matching: duke scientific
CHAMPION PCI: Cangrelor not superior to clopidogrel in patients undergoing PCI
Cardiology Today:  Nov 16 2009 3:42AM Matching: duke scientific
The Medicines Company's Full Analysis of CHAMPION Phase III Data Shows Cangrelor Significantly Improves Patien
Freshnews.com:  Nov 15 2009 2:09PM Matching: duke scientific
The Medicines Company's Full Analysis of CHAMPION Phase III Data Shows Cangrelor Significantly Improves Patien
Genetic Engineering News:  Nov 15 2009 4:07PM Matching: duke scientific
Promote your company here: BioNewsCast - Press Release Distribution

View more Duke ScientificCorporation news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 312 times since April 2007, the link to the organisation's website has been followed 43 times

Search for more companies in Fremont

Search for more companies in California



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Duke ScientificCorporation

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.